Company news
enVVeno Medical Corporation news in 2024
enVVeno Medical Corporation's news releases, calls and decks from 2024, newest first.
Proxy Results Form 8 K
December 26, 2024
enVVeno Medical Successfully Completes Final Wave of Implants in Pre-Clinical GLP Study for enVVe
December 15, 2024
enVVeno Medical Highlights Successful 2024 VEITH Symposium with Launch of Recap Website
November 26, 2024
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
November 19, 2024
enVVeno Medical Submits the VenoValve PMA Application Seeking FDA Approval
November 18, 2024
EnVVeno Medical Reports Third Quarter 2024 Financial Results
November 1, 2024
enVVeno Medical Reports Third Quarter 2024 Financial Results and Confirms Guidance for Release of Definitive VenoValve Data in November and Completion of FDA Premarket Approval Application for VenoValve in Q4 of this Year
October 30, 2024
enVVeno Medical Successfully Initiates 6-Month Pre-Clinical GLP Study Evaluating enVVe(R)
October 27, 2024
enVVeno Medical Corporation Announces Proposed Public Offering
September 25, 2024
enVVeno Medical Corporation Announces Pricing of $15.0 Million Public Offering
September 25, 2024
enVVeno Medical Adds Sandy Prietto to its Executive Team as Vice President of Marketing
September 2, 2024
EnVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve
August 15, 2024
enVVeno Medical Provides Update on FDA Premarket Approval Application Status for VenoValve(R)
August 13, 2024
EnVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
August 2, 2024
enVVeno Medical Reports Second Quarter 2024 Financial Results and Provides Corporate Update
July 31, 2024
Positive Interim Venous Ulcer Healing Data Showing Significant Improvement from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented Today at the Society for Vascular Surgery 2024 Vascular Annual Meeting
June 20, 2024
EnVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 9, 2024
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 7, 2024
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
April 8, 2024
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
February 28, 2024
Decks in 2024
- VEITH Symposium 2024
Conference · 65 slides · November 2024